Crispr Therapeutics
Price & Volume
Stats
See moreOpen | $62.22 |
Previous Close | $61.67 |
Day Range | $61.59-$63.10 |
52W Range | $30.04-$71.13 |
Market Cap | $5.6B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $38M |
Revenue Growth (YoY) | 72.5% |
Gross Profit (12 Mos) | -$382.4M |
Diluted EPS | -$5.40 |
News
See moreYahoo Finance • 4 days ago
Interesting CRSP Put And Call Options For November 7th
Yahoo Finance • 7 days ago
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
Yahoo Finance • 11 days ago
CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects
Yahoo Finance • 11 days ago
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
